~~<i id='D950E658A1'><strike id='D950E658A1'><tt id='D950E658A1'><pre id='D950E658A1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

Wikipedia

author：Wikipedia 2025-08-11 10:53:27 - browse：97344

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Florida babysitter arrested over hot car death, authorities say

Wikipedia

entertainment

explore

leisure time

hotspot

entertainment

DebatesoverCovid'soriginshavebroughtnewattentiontotherisksofgain-of-functionresearch,butnotthebenefi

WSS

Curing rare childhood diseases will falter unless Congress steps up

STAT Virtual Event: ASCO Recap, Live!

Cheap, fast test for Zika and dengue could cost just $1

Health care court cases: Humana, Sutter, Novant

Reframing the conversation around gain

Coercive sterilizations revealed by STAT prompt outrage

hotspot

Wikipedia

Wikipedia

State Dept. review finds Biden bears some blame for Afghanistan failures

STAT Virtual Event: ASCO Recap, Live!

Duchenne breakthrough therapy leaves behind pioneering families

EMA weighs against approval for Mirati's lung cancer drug

Medicare details structure of new drug price negotiation program

Reframing the conversation around gain

Dobbs anniversary: the lost opportunity of abortion as health care

Medical device trials still don't enroll enough women, study finds

Moonlake's readout produced a cash windfall. Risks remain

'The View' co

entertainment

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Study: Why relieving medical debt did not improve financial outcomes

EMA weighs against approval for Mirati's lung cancer drug

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

STAT Virtual Event: ASCO Recap, Live!

explore

leisure time

hotspot

entertainment